CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $21,672,000 | +11.1% | 350,000 | -1.7% | 2.83% | -25.8% |
| Q3 2020 | $19,509,000 | -6.3% | 356,000 | -1.5% | 3.82% | -9.3% |
| Q2 2020 | $20,816,000 | +43.3% | 361,600 | 0.0% | 4.20% | +9.2% |
| Q1 2020 | $14,529,000 | +4.9% | 361,600 | 0.0% | 3.85% | +41.7% |
| Q4 2019 | $13,846,000 | +921.1% | 361,600 | +80.8% | 2.72% | +454.5% |
| Q3 2019 | $1,356,000 | – | 200,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |